Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Renée D. Galá
CEORenée D. Galá
Employees
2,890
Employees2,890
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,890
Employees2,890

JAZZ Key Statistics

Market cap
16.43B
Market cap16.43B
Price-Earnings ratio
-13,797.28
Price-Earnings ratio-13,797.28
Dividend yield
Dividend yield
Average volume
620.36K
Average volume620.36K
High today
$256.75
High today$256.75
Low today
$250.30
Low today$250.30
Open price
$255.83
Open price$255.83
Volume
533.15K
Volume533.15K
52 Week high
$256.75
52 Week high$256.75
52 Week low
$105.00
52 Week low$105.00

Stock Snapshot

Jazz Pharmaceuticals(JAZZ) stock is priced at $253.87, giving the company a market capitalization of 16.43B. It carries a P/E multiple of -13797.28.

On 2026-07-27, Jazz Pharmaceuticals(JAZZ) stock traded between a low of $250.30 and a high of $256.75. Shares are currently priced at $253.87, which is +1.4% above the low and -1.1% below the high.

Jazz Pharmaceuticals(JAZZ) shares are trading with a volume of 533.15K, against a daily average of 620.36K.

During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $105.00 at its lowest and $256.75 at its peak.

During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $105.00 at its lowest and $256.75 at its peak.

JAZZ News

Simply Wall St 1d
Jazz Pharmaceuticals Stock Still Looks Cheap As Shares Jumped 115%

Jazz Pharmaceuticals has delivered a strong share price run over the past year, yet its current valuation checks still flag a mixed picture rather than a clear...

Jazz Pharmaceuticals Stock Still Looks Cheap As Shares Jumped 115%
TipRanks 3d
Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy

Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 3d
Jazz Targets Epilepsy Growth With New JZP926 Trial in Juvenile Myoclonic Epilepsy

Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Analyst ratings

86%

of 22 ratings
Buy
86.4%
Hold
4.5%
Sell
9.1%

More JAZZ News

TipRanks 3d
Jazz Pharmaceuticals Shareholders Reaffirm Board and Governance Plans

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 7d
Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial

Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.